Preliminary Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...
Today Emergent BioSolutions (NYSE: EBS) announced it has received a delivery order valued at up to $21.5 million from the U.S. Department of War to ...
Phase 3 programs underway for DURAVYU in wet AMD and DME, the largest multi-billion-dollar retinal disease markets - - Pivotal Phase 3 trials in wet AMD on track for data readout beginning in mid-2026 ...
News-Medical.Net on MSN
Self-administered injectable contraceptives face provider hesitancy despite availability
Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new ...
Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new ...
A treatment that blocks an age-related protein restored cartilage in aging and injured joints by reprogramming existing cells ...
Your health should be your top priority at all times. It is the foundation for everything else that you do in life. You know ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback